The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone

BACKGROUND: Simplistic two-dimensional (2D) in vitro assays have long been the standard for studying the metastatic abilities of cancer cells. However, tri-dimensional (3D) organotypic models provide a more complex environment, closer to that seen in patients, and thereby provide a more accurate rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritch, Sabrina J., Noman, Abu Shadat M., Goyeneche, Alicia A., Telleria, Carlos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733158/
https://www.ncbi.nlm.nih.gov/pubmed/36494669
http://dx.doi.org/10.1186/s12935-022-02822-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733158/
https://www.ncbi.nlm.nih.gov/pubmed/36494669
http://dx.doi.org/10.1186/s12935-022-02822-5

Ejemplares similares